Adjuvant therapy in conservative surgery for adenomyosis.
Xiaopei ChaoXiaochen SongHuanwen WuYan YouLei LiJinghe LangPublished in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2021)
Perioperative adjuvant therapy with GnRHa and/or the LNG-IUS can significantly reduce disease recurrence or progression for adenomyosis patients undergoing uterus-sparing surgery. Older patients are more likely to experience disease recurrence.